bluebird (BLUE) Underperforms Industry YTD Amid Challenges
Yahoo Finance · 2 weeks ago
Genzyme
Search results
- 0.9049Add to watchlist+0.0016 (+0.18%)As of Fri. May 3, 2024 12:58 PM EDT · Nasdaq Real Time Price (USD) · Market open
- Open0.9200High0.9447Low0.8903
- Mkt Cap174.41MP/E (TTM)N/ADiv & YieldN/A & N/A
- Prev. Close0.903352 Wk. Low0.860052 Wk. High5.5300
Top storiesRelated stocks
Find the latest bluebird bio, Inc. (BLUE) stock quote, history, news and other vital information to help you with your stock trading and investing.
Mar 26, 2024 · Discover real-time bluebird bio, Inc. Common Stock (BLUE) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.
Apr 26, 2024 · Key Data. Open $0.8946. Day Range 0.8700 - 0.9480. 52 Week Range 0.8618 - 5.5300. Market Cap $170.98M. Shares Outstanding 107.02M. Public Float 189.83M. Beta 1.37. Rev. per Employee $91.33K.
323. Get the latest bluebird bio Inc (BLUE) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Apr 11, 2024 · stock quote. NASDAQ: (common stock) Data Provided by Refinitiv. Minimum 15 minutes delayed. press releases. 4/11/2024. bluebird bio Reports Inducement Grants Under Nasdaq Listing Rule 5635 (c) (4)
View the latest bluebird bio Inc. (BLUE) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Apr 25, 2024 · According to 12 analysts, the average rating for BLUE stock is "Hold." The 12-month stock price forecast is $5.79, which is an increase of 527.44% from the latest price.
